SHSAX vs. MXMGX

Last updated Jun 23, 2026

SHSAX (BlackRock Health Sciences Opportunities Portfolio) and MXMGX (Great-West T. Rowe Price Mid Cap Growth Fund) are both mutual funds - SHSAX is a Health & Biotech Equities fund managed by BlackRock, while MXMGX is a Mid Cap Growth Equities fund managed by T. Rowe Price. Over the past 10 years, SHSAX returned 9.67%/yr vs 9.06%/yr for MXMGX. A 0.72 correlation means they provide meaningful diversification when combined. SHSAX charges 1.09%/yr vs 1.02%/yr for MXMGX.

Performance

SHSAX vs. MXMGX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BlackRock Health Sciences Opportunities Portfolio (SHSAX) and Great-West T. Rowe Price Mid Cap Growth Fund (MXMGX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, SHSAX achieves a -2.94% return, which is significantly lower than MXMGX's 1.63% return. Over the past 10 years, SHSAX has outperformed MXMGX with an annualized return of 9.67%, while MXMGX has yielded a comparatively lower 9.06% annualized return.

SHSAX

• 1D: -0.65%
• 1M: 0.38%
• YTD: -2.94%
• 6M: -3.69%
• 1Y: 16.32%
• 3Y*: 6.12%
• 5Y*: 3.78%
• 10Y*: 9.67%

MXMGX

• 1D: 1.07%
• 1M: 0.62%
• YTD: 1.63%
• 6M: -0.20%
• 1Y: 6.41%
• 3Y*: 6.97%
• 5Y*: 2.68%
• 10Y*: 9.06%

*Multi-year figures are annualized to reflect compound growth (CAGR)

SHSAX vs. MXMGX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
SHSAX BlackRock Health Sciences Opportunities Portfolio	-2.94%	15.85%	3.73%	3.59%	-5.94%	11.88%	19.44%	25.27%	7.93%	24.74%
MXMGX Great-West T. Rowe Price Mid Cap Growth Fund	1.63%	2.99%	9.02%	19.61%	-22.82%	15.25%	23.65%	31.28%	-2.80%	23.89%

Correlation

The correlation between SHSAX and MXMGX is 0.54, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.54
Correlation (3Y) Calculated over the trailing 3-year period	0.55
Correlation (5Y) Calculated over the trailing 5-year period	0.63
Correlation (10Y) Calculated over the trailing 10-year period	0.68
Correlation (All Time) Calculated using the full available price history since Jan 3, 2000	0.72

The correlation between SHSAX and MXMGX shifts across timeframes, from 0.54 (1 year) to 0.72 (all time), reflecting how their relationship changes across market environments.

Return for Risk

SHSAX vs. MXMGX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SHSAX

SHSAX Risk / Return Rank: 18
SHSAX Sharpe Ratio Rank: 18
SHSAX Sortino Ratio Rank: 20
SHSAX Omega Ratio Rank: 17
SHSAX Calmar Ratio Rank: 22
SHSAX Martin Ratio Rank: 15

MXMGX

MXMGX Risk / Return Rank: 7
MXMGX Sharpe Ratio Rank: 6
MXMGX Sortino Ratio Rank: 6
MXMGX Omega Ratio Rank: 6
MXMGX Calmar Ratio Rank: 7
MXMGX Martin Ratio Rank: 8

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SHSAX vs. MXMGX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for BlackRock Health Sciences Opportunities Portfolio (SHSAX) and Great-West T. Rowe Price Mid Cap Growth Fund (MXMGX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	SHSAX	MXMGX	Difference
Sharpe ratio: Return per unit of total volatility	1.13	0.48	+0.65
Sortino ratio: Return per unit of downside risk	1.76	0.79	+0.97
Omega ratio: Gain probability vs. loss probability	1.20	1.09	+0.11
Calmar ratio: Return relative to maximum drawdown	1.62	0.65	+0.97
Martin ratio: Return relative to average drawdown	3.91	2.16	+1.75

SHSAX vs. MXMGX - Sharpe Ratio Comparison

The current SHSAX Sharpe Ratio is 1.13, which is higher than the MXMGX Sharpe Ratio of 0.48. The chart below compares the historical Sharpe Ratios of SHSAX and MXMGX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

SHSAX vs. MXMGX - Drawdown Comparison

The maximum SHSAX drawdown since its inception was -35.49%, smaller than the maximum MXMGX drawdown of -60.97%. Use the drawdown chart below to compare losses from any high point for SHSAX and MXMGX.

Drawdown Indicators

	SHSAX	MXMGX	Difference
Max Drawdown Largest peak-to-trough decline	-35.49%	-60.97%	+25.48%
Max Drawdown (1Y) Largest decline over 1 year	-9.87%	-10.29%	+0.42%
Max Drawdown (3Y) Largest decline over 3 years	-16.08%	-23.17%	+7.09%
Max Drawdown (5Y) Largest decline over 5 years	-17.99%	-32.33%	+14.34%
Max Drawdown (10Y) Largest decline over 10 years	-28.36%	-35.88%	+7.52%
Current Drawdown Current decline from peak	-5.73%	-2.22%	-3.51%
Average Drawdown Average peak-to-trough decline	-6.17%	-11.78%	+5.61%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.08%	3.03%	+1.05%

Volatility

SHSAX vs. MXMGX - Volatility Comparison

BlackRock Health Sciences Opportunities Portfolio (SHSAX) has a higher volatility of 4.95% compared to Great-West T. Rowe Price Mid Cap Growth Fund (MXMGX) at 4.66%. This indicates that SHSAX's price experiences larger fluctuations and is considered to be riskier than MXMGX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SHSAX	MXMGX	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.95%	4.66%	+0.29%
Volatility (6M) Calculated over the trailing 6-month period	10.65%	10.73%	-0.08%
Volatility (1Y) Calculated over the trailing 1-year period	14.14%	13.77%	+0.37%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	14.44%	19.06%	-4.62%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	16.56%	18.98%	-2.42%

SHSAX vs. MXMGX - Expense Ratio Comparison

SHSAX has a 1.09% expense ratio, which is higher than MXMGX's 1.02% expense ratio.

Dividends

SHSAX vs. MXMGX - Dividend Comparison

SHSAX's dividend yield for the trailing twelve months is around 10.96%, more than MXMGX's 1.65% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
MXMGX Great-West T. Rowe Price Mid Cap Growth Fund	1.65%	1.68%	3.66%	2.39%	2.66%	4.92%	2.74%	2.19%	6.13%	4.53%	0.00%	0.00%
SHSAX BlackRock Health Sciences Opportunities Portfolio	10.96%	10.63%	9.18%	3.84%	7.44%	9.20%	4.34%	3.89%	8.56%	3.53%	2.43%	12.58%

Frequently Asked Questions

Can I hold both SHSAX and MXMGX in my portfolio?

SHSAX and MXMGX have a correlation of 0.54, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, SHSAX or MXMGX?

SHSAX has higher volatility (4.95%) compared to MXMGX (4.66%). In terms of maximum drawdown, SHSAX dropped -35.49% vs MXMGX's -60.97%.

Which has better risk-adjusted returns?

SHSAX currently has the higher Sharpe Ratio (1.13 vs 0.48), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.